Skip to main content
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1984 Feb;65(1):1–9.

The role of muramyl dipeptide in the therapy of established experimental bacterial infection.

J R Ausobsky, M Scuitto, L S Trachtenberg, H C Polk Jr
PMCID: PMC2040944  PMID: 6365142

Abstract

Muramyl dipeptide (MDP) actively potentiates host defences and confers protection when given before a bacterial challenge. Experiments were undertaken to characterize its actions when used alone or in combination with cephaloridine in a manner analogous to clinical therapy, i.e. after initiation of bacterial infection. MDP, alone or in combination, significantly decreased the systemic manifestations of infection compared with placebo when administered up to 6 h following bacterial contamination. Its effect on the primary lesion was less marked, but it may potentiate host defences sufficiently to have an impact on the decisive period. Benefits observed in this study were of lesser magnitude than those observed following administration of the dipeptide before bacterial inoculation.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calhoun K., Trachtenberg L., Hart K., Polk H. C., Jr Corynebacterium parvum: immunomodulation in local bacterial infections. Surgery. 1980 Jan;87(1):52–58. [PubMed] [Google Scholar]
  2. Chedid L., Parant M., Parant F., Lefrancher P., Choay J., Lederer E. Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs. Proc Natl Acad Sci U S A. 1977 May;74(5):2089–2093. doi: 10.1073/pnas.74.5.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DUBOS R. J., SCHAEDLER R. W. Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins. J Exp Med. 1956 Jul 1;104(1):53–65. doi: 10.1084/jem.104.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fauve R. M., Hevin B. Immunostimulation with bacterial phospholipid extracts. Proc Natl Acad Sci U S A. 1974 Feb;71(2):573–577. doi: 10.1073/pnas.71.2.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fraser-Smith E. B., Matthews T. R. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice. Infect Immun. 1981 Dec;34(3):676–683. doi: 10.1128/iai.34.3.676-683.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Freund J., Sommer H. E., Walter A. W. IMMUNIZATION AGAINST MALARIA: VACCINATION OF DUCKS WITH KILLED PARASITES INCORPORATED WITH ADJUVANTS. Science. 1945 Aug 24;102(2643):200–202. doi: 10.1126/science.102.2643.200. [DOI] [PubMed] [Google Scholar]
  7. MILES A. A., MILES E. M., BURKE J. The value and duration of defence reactions of the skin to the primary lodgement of bacteria. Br J Exp Pathol. 1957 Feb;38(1):79–96. [PMC free article] [PubMed] [Google Scholar]
  8. Rouben D. P., Fagelman K., McCoy M. T., Polk H. C., Jr Enhancement of nonspecific host defenses against local bacterial challenge. Surg Forum. 1977;28:44–45. [PubMed] [Google Scholar]

Articles from British journal of experimental pathology are provided here courtesy of Wiley

RESOURCES